Companies / Denali Therapeutics Inc. / Activity
Activity — Denali Therapeutics Inc.
12 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | Watts Ryan J. CEO | Sell | Common Stock | $580.8K | -35K -10.60% | 296,833 0.19% of shares | medium |
| Jan 6, 2026 | Schuth Alexander O. Executive | Sell | Common Stock | $284.1K | -17K -5.74% | 282,828 0.18% of shares | medium |
| Jun 3, 2026 | Flatley Jay T Director | Grant | Common Stock | $0 | +6K +39.51% | 22,628 0.01% of shares | low |
| Jun 3, 2026 | Baker Bros. Advisors LP Director | Grant | Common Stock | $0 | +6K +0.19% | 3,422,366 2.14% of shares | low |
| Jun 3, 2026 | Baker Bros. Advisors LP Director | Grant | Common Stock | $0 | +6K +1.90% | 343,275 0.21% of shares | low |
| Jan 3, 2026 | Schuth Alexander O. Executive | Grant | Common Stock | $0 | +58K +23.81% | 300,046 0.19% of shares | low |
| Jan 3, 2026 | Watts Ryan J. CEO | Grant | Common Stock | $0 | +79K +31.20% | 332,031 0.21% of shares | low |
| Jun 3, 2026 | Flatley Jay T Director | Grant | Stock Option (right to buy) | — | +19K | 19,226 0.01% of shares | low |
| Jun 3, 2026 | Baker Bros. Advisors LP Director | Grant | Non- Qualified Stock Option (right to buy) | — | +19K | 19,226 0.01% of shares | low |
| Jun 3, 2026 | Baker Bros. Advisors LP Director | Grant | Non-Qualified Stock Option (right to buy) | — | +19K | 19,226 0.01% of shares | low |
| Jan 3, 2026 | Schuth Alexander O. Executive | Grant | Stock Option (right to buy) | — | +173K | 173,100 0.11% of shares | low |
| Jan 3, 2026 | Watts Ryan J. CEO | Grant | Stock Option (right to buy) | — | +237K | 236,880 0.15% of shares | low |